Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-12-22
1994-03-22
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 54, 536 21, A61K 31725, C08R 3710
Patent
active
052964710
ABSTRACT:
Methods of making and using, as prophylatics or therapeutics for preventing or treating certain diseases including cancer, O-desulfated heparin compositions, preferably 2-O, 3-O desulfated heparin compositions, wherein the methods permit regulating the degree of 2-O, 3-O desulfation to produce compositions that are variably desulfated including about 99% and 75% desulfated at the 2-O and 3-O positions, respectively.
REFERENCES:
patent: 5010063 (1991-04-01), Piani et al.
patent: 5104860 (1992-04-01), Piani et al.
Irimura et al. Biochemistry 1986 25 pp. 5322-5328.
Bar-Ner et al. Blood 70(2) 1987 pp. 551-557.
Rone et al. Endocrinology 127(6) 1990 pp. 2821-2828.
Stokes et al. Lab Invest 63(5) 1990 pp. 657-668.
Article by Guo, et al., entitled "The Disaccharide Composition of Heparins and Heparan Sulfates" published by Academic Press, Inc., Analytical Biochemistry 176:96-104 (1989).
Article by Jaseja, et al., entitled "Novel Regio-and Stereoselective Modifications of Heparin in Alkaline Solution. Nuclear Magnetic Resonance Spectroscopic Evidence" published by Can. J. Chem., 67:1449-1456 (1989).
Article by Rej, et al., entitled "Base-catalyzed Conversion of the .alpha.-L-iduronic acid 2-sulfate Unit of Heparin into a Unit of .alpha.-L-galacturonic Acid, and Related Reactions" published by Elsevier Science Publishers B.V., (1989).
Article by Liu, et al., entitled "Adverse Effects of Alkali and Acid on the Antiocoagulant Potency of Heparin, Evaluated with Methyl 2-deoxy-2-sulfamino-.alpha.-D-Glucopyranoside 3-Sulfate as a Model Compound" published by Elsevier Science Publishers B.V., Amsterdam, Carbohydrate Research, 228:29-36 (1992).
Article by Fraidenraich, et al., entitled "Selective O-desulphation of Heparin in Triethylamine" published by Elsevier Science Publishers, Ltd., Carbohydrate Polymers, pp. 111-114 (1991).
Article by Mitchell, et al., entitled "Inhibitors of Angiogenesis" published by Academic Press, Inc., pp. 139-148 (1992).
Article by Hirsh, et al., entitled "Low Molecular Weight Heparin" published by The Journal of The American Society of Hematology, Blood, 79, No. 1:1-17 (1992).
Article by Castellot, et al., entitled "Heparin Potentiation of 3T3-Adipocyte Stimulated Angiogenesis:Mechanisms of Action on Endothelial Cells" published by Journal of Cellular Physiology, pp. 323-329 (1986).
Article by Ishihara, et al., entitled "A Cell-Based Assay for Evaluating the Interaction of Heparin-like Molecules and Basic Fibroblast Growth Factor" published by Academic Press, Inc., 202:310-315 (1992).
Holme Kevin R.
Shaklee Patrick N.
Tyrrell David J.
Giotta Gregory J.
Glycomed Incorporated
Lilling Herbert J.
LandOfFree
Method for controlling o-desulfation of heparin and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for controlling o-desulfation of heparin and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for controlling o-desulfation of heparin and compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437192